Alliancebernstein L.P. Vanda Pharmaceuticals Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 112,133 shares of VNDA stock, worth $525,903. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,133

Previous 116,963 4.13%

Holding current value

$525,903

Previous $660,000 20.45%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.61 - $6.34 $22,266 - $30,622	-4,830 Reduced 4.13%	112,133 $525,000
Q2 2024 Aug 14, 2024	BUY	$3.91 - $6.5 $94,973 - $157,885	24,290 Added 26.21%	116,963 $660,000
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $24,336 - $32,976	-7,200 Reduced 7.21%	92,673 $391,000
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $104,988 - $161,162	24,530 Added 32.56%	99,873 $431,000
Q2 2023 Aug 15, 2023	BUY	$5.9 - $6.95 $69,266 - $81,593	11,740 Added 18.46%	75,343 $496,000
Q1 2023 May 15, 2023	SELL	$6.18 - $7.99 $51,615 - $66,732	-8,352 Reduced 11.61%	63,603 $431,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $370 - $591	54 Added 0.08%	71,955 $531,000
Q3 2022 Nov 15, 2022	BUY	$9.44 - $11.76 $792 - $987	84 Added 0.12%	71,901 $710,000
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $929,231 - $1.18 Million	-99,810 Reduced 58.16%	71,817 $783,000
Q1 2022 May 13, 2022	BUY	$10.84 - $16.55 $1.09 Million - $1.66 Million	100,280 Added 140.55%	171,627 $1.94 Million
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $782,240 - $1.05 Million	-49,856 Reduced 41.13%	71,347 $1.12 Million
Q3 2021 Nov 10, 2021	BUY	$15.35 - $21.27 $728,818 - $1.01 Million	47,480 Added 64.4%	121,203 $2.08 Million
Q1 2021 May 06, 2021	BUY	$13.42 - $20.28 $1,878 - $2,839	140 Added 0.19%	73,723 $1.11 Million
Q3 2020 Nov 12, 2020	BUY	$9.32 - $12.02 $1,770 - $2,283	190 Added 0.26%	73,583 $711,000
Q2 2020 Aug 13, 2020	SELL	$9.66 - $12.02 $19,416 - $24,160	-2,010 Reduced 2.67%	73,393 $840,000
Q1 2020 May 14, 2020	BUY	$7.5 - $16.8 $750 - $1,680	100 Added 0.13%	75,403 $781,000
Q4 2019 Feb 18, 2020	BUY	$12.38 - $17.47 $4,333 - $6,114	350 Added 0.47%	75,303 $1.24 Million
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $146,626 - $188,690	-11,950 Reduced 13.75%	74,953 $995,000
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $879,879 - $1.24 Million	-65,810 Reduced 43.09%	86,903 $1.22 Million
Q4 2018 Feb 13, 2019	SELL	$18.97 - $31.47 $152,518 - $253,018	-8,040 Reduced 5.0%	152,713 $3.99 Million
Q2 2018 Aug 13, 2018	BUY	$13.95 - $19.15 $711,310 - $976,458	50,990 Added 46.45%	160,753 $3.06 Million
Q4 2017 Feb 13, 2018	SELL	$12.85 - $18.1 $59,110 - $83,260	-4,600 Reduced 4.02%	109,763 $1.67 Million
Q3 2017 Nov 13, 2017	BUY	$15.4 - $18.85 $1.76 Million - $2.16 Million	114,363	114,363 $2.05 Million

Others Institutions Holding VNDA

# of Institutions

156

Shares Held

44.7M

Call Options Held

167K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $265M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Vanda Pharmaceuticals Inc. Transaction History